Patrick Jamnik - Episurf Medical President
| EPIS-B Stock | SEK 0.15 0.01 7.14% |
Insider
Patrick Jamnik is President of Episurf Medical AB
| Age | 40 |
| Phone | 46 86 12 00 20 |
| Web | https://episurf.com |
Episurf Medical Management Efficiency
The company has return on total asset (ROA) of (0.2577) % which means that it has lost $0.2577 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.4506) %, meaning that it generated substantial loss on money invested by shareholders. Episurf Medical's management efficiency ratios could be used to measure how well Episurf Medical manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Showing other executives | INSIDER Age | ||
| Johanna Tulkki | Senzime AB | 53 | |
| Anders Selin | Senzime AB | 61 | |
| Jaya Tiwari | Xvivo Perfusion AB | N/A | |
| Katrin Gisselfalt | Xvivo Perfusion AB | 54 | |
| Charlotte Walldal | Xvivo Perfusion AB | 56 | |
| Kristoffer Nordstrom | Xvivo Perfusion AB | 38 | |
| Lena BSc | Xvivo Perfusion AB | 58 | |
| Mirjam Johansson | SpectraCure AB | N/A | |
| Henrik Ljung | SpectraCure AB | 65 | |
| Kristina Holst | SpectraCure AB | N/A | |
| Johan Folkunger | SpectraCure AB | 55 | |
| Slavoljub Grujicic | Senzime AB | 53 | |
| Johan Holmstrom | Xvivo Perfusion AB | 53 | |
| Andreas MD | Xvivo Perfusion AB | 46 | |
| Johannes Swartling | SpectraCure AB | 51 | |
Management Performance
| Return On Equity | -0.45 | |||
| Return On Asset | -0.26 |
Episurf Medical AB Leadership Team
Elected by the shareholders, the Episurf Medical's board of directors comprises two types of representatives: Episurf Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Episurf. The board's role is to monitor Episurf Medical's management team and ensure that shareholders' interests are well served. Episurf Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Episurf Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Veronica Wallin, Chief Officer | ||
| Katarina Flodstrm, Chief Officer | ||
| Michael Nsstrm, Head Affairs | ||
| Beata Lihammar, Principal Auditor | ||
| Pal Ryfors, Chief Officer | ||
| Stephen Caswell, Head OUS | ||
| Fredrik Zetterberg, Marketing Director | ||
| Patrick Jamnik, President |
Episurf Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Episurf Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -0.45 | |||
| Return On Asset | -0.26 | |||
| Operating Margin | (11.71) % | |||
| Current Valuation | 291.48 M | |||
| Shares Outstanding | 266.43 M | |||
| Shares Owned By Insiders | 21.11 % | |||
| Shares Owned By Institutions | 12.17 % | |||
| Price To Earning | (2.21) X | |||
| Price To Book | 2.31 X | |||
| Price To Sales | 74.39 X |
Thematic Opportunities
Explore Investment Opportunities
Other Information on Investing in Episurf Stock
Episurf Medical financial ratios help investors to determine whether Episurf Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Episurf with respect to the benefits of owning Episurf Medical security.